Darya Bubman, PhD

Senior Manager, Business Development & EOD
Office of Technology Management
+1 415 237-1585

In her role on the Engagement and Opportunity Development (EOD) team of UCSF’s OTM, Darya evaluates novel UCSF inventions for market opportunity, identifies technologies that a start-up company could be built around, works on developing business opportunities for such promising new ventures and negotiates start-up licenses. Darya is also the lead for developing and maintaining the EOD Key Opinion Leader network of early-stage investors and industry as well as the EOD EiR Program.

Darya joined OTM in November 2011. She earned a B.A. degree in Biochemistry from Cornell University in Ithaca, N.Y. and a Ph.D. in Pharmacology from the Weill Cornell Graduate School of Medical Sciences in New York City. She conducted her doctoral work in the laboratory of Dr. Ethel Cesarman, studying deregulation of cancer signaling pathways by the Kaposi’s sarcoma-associated herpesvirus (KSHV) in primary effusion lymphoma, a rare cancer that occurs in immunocompromised individuals. Following her graduate studies, Darya became an AAAS Science and Technology Policy Fellow and worked at the U.S. State Department on international issues related to biomedical IP, access to medicines and innovation. Prior to joining the OTM, she worked as a Technology Partnerships Manager for biomedical inventions at the NASA Ames Research Center located at Moffett Field, CA. Darya has a strong background in molecular biology, oncology and pharmacology.

Darya is passionate about working with UCSF faculty and staff to nurture new venture opportunities that have the potential to improve health on a global scale and change the world for the better.

Publications: 

Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome.

American journal of clinical pathology

Czuchlewski DR, Csernus B, Bubman D, Hyjek E, Martin P, Chadburn A, Knowles DM, Cesarman E

Pathogenesis of Kaposi's sarcoma.

Hematology/oncology clinics of North America

Bubman D, Cesarman E

Role of a novel soluble nucleotide phospho-hydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology.

The Journal of laboratory and clinical medicine

Birk AV, Bubman D, Broekman MJ, Robertson HD, Drosopoulos JH, Marcus AJ, Szeto HH